KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $35.67 $42.36 Friday, 26th Apr 2024 CLDX stock ended at $36.30. This is 0.110% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.00% from a day low at $35.67 to a day high of $36.74.
90 days $34.65 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
Mar 07, 2016 $56.40 $64.95 $55.50 $56.85 1 558 467
Mar 04, 2016 $124.65 $127.95 $119.70 $122.85 211 300
Mar 03, 2016 $125.40 $131.25 $122.25 $123.75 216 220
Mar 02, 2016 $112.65 $125.55 $111.45 $124.65 345 707
Mar 01, 2016 $106.65 $115.65 $105.00 $112.50 363 073
Feb 29, 2016 $113.70 $114.75 $102.00 $102.00 261 860
Feb 26, 2016 $105.60 $114.60 $99.45 $114.30 326 913
Feb 25, 2016 $111.60 $115.50 $103.35 $103.65 377 780
Feb 24, 2016 $99.90 $103.65 $93.90 $103.05 294 613
Feb 23, 2016 $105.00 $106.80 $100.35 $100.35 210 767
Feb 22, 2016 $107.40 $109.20 $100.20 $105.15 212 447
Feb 19, 2016 $105.15 $106.20 $101.25 $105.00 142 087
Feb 18, 2016 $112.50 $113.70 $100.95 $105.00 198 047
Feb 17, 2016 $116.40 $118.35 $108.90 $112.35 227 647
Feb 16, 2016 $112.20 $115.95 $107.70 $115.35 247 820
Feb 12, 2016 $102.30 $109.95 $98.55 $108.75 193 420
Feb 11, 2016 $94.80 $103.80 $93.75 $101.10 209 847
Feb 10, 2016 $105.90 $108.75 $96.45 $96.75 281 540
Feb 09, 2016 $99.75 $110.10 $97.50 $104.70 224 507
Feb 08, 2016 $106.35 $107.25 $100.05 $102.60 259 000
Feb 05, 2016 $110.25 $113.10 $100.50 $108.90 492 620
Feb 04, 2016 $106.95 $117.45 $101.55 $110.70 314 093
Feb 03, 2016 $112.95 $115.35 $101.25 $108.60 283 907
Feb 02, 2016 $121.05 $121.65 $108.15 $112.05 319 793
Feb 01, 2016 $125.85 $125.85 $116.25 $122.85 252 193
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT